Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
January 6, 2022 11:31 AM 2 min read

Analyst Downgrades Goldman Sachs, Prefers Morgan Stanley And Wells Fargo

by Wayne Duggan Benzinga Staff Writer
Follow
FlipboardIcon version of the Flipboard logo

With big bank earnings just around the corner, one analyst has downgraded Goldman Sachs Group Inc (NYSE:GS) and said there’s little change of earnings upside in the near term.

The Analyst: On Thursday, Bank of America analyst Ebrahim Poonawala downgraded Goldman Sachs from Buy to Neutral and cut his price target from $490 to $475.

Related Links: Why A Federal Reserve Interest Rate Hike Could Be Closer Than You Think

The Thesis: In the downgrade note, Poonawala said Goldman has an impressive asset management business, but it has yet to prove its consumer and wealth management strategy will pay off for investors.

Poonawala said he expects a tough year for growth in capital markets revenue in 2022 for Goldman and anticipates a cool-down in both trading activity and IPO activity this year. In addition, he said Federal Reserve rate hikes could weigh on investor enthusiasm for non-profitable startups.

Instead of Goldman, Poonawala said he prefers investment bank competitor Morgan Stanley (NYSE:MS) ahead of big bank earnings season.

“We believe that Morgan Stanley-MS offers a better risk/reward-driven by a more defensible revenue profile (approx. 40% of revenues derived from wealth and investment management), rate sensitivity (100bp in higher interest rates = $1.5bn to spread revenue), potential to drive deal synergies (Eaton Vance, E*Trade, Solium) and exposure to higher growth (= higher P/E) businesses,” Poonawala said.

Poonawala also named Wells Fargo & Co (NYSE:WFC) his top overall big bank stock pick due to its EPS sensitivity to interest rates and its lending rebound potential. He is also bullish on Citigroup Inc (NYSE:C) ahead of its upcoming investor day event in March.

Benzinga’s Take: After a big year in 2021, investors again have some high expectations for bank stocks in 2022. The higher interest rates rise, the more net interest income banks can generate from their lending businesses.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorNewsDowngradesPrice TargetAnalyst RatingsTrading IdeasBank of AmericaEbrahim Poonawala
GS Logo
GSThe Goldman Sachs Group Inc
$818.75-0.33%
Overview
C Logo
CCitigroup Inc
$106.05-0.45%
MS Logo
MSMorgan Stanley
$160.00-0.17%
WFC Logo
WFCWells Fargo & Co
$80.30-0.15%
GS Logo
GSThe Goldman Sachs Group Inc
$818.75-0.33%
Overview
C Logo
CCitigroup Inc
$106.05-0.45%
MS Logo
MSMorgan Stanley
$160.00-0.17%
WFC Logo
WFCWells Fargo & Co
$80.30-0.15%
Comments
Loading...